4.10.13.4Vertical

Nephrology Management Organizations

PE-backed platforms consolidating nephrology practices nationally.

Market snapshot

These figures describe Nephrology & Dialysis (4.10.13), the segment that Nephrology Management Organizations sits within. They are not figures for Nephrology Management Organizations on its own.

Market size
~$30B
Growth
~3.9%CAGR (2017–22, nominal)
Companies
~507 firms
Firms by employee count

63.3% of firms have fewer than 20 employees: 321 micro-businesses, below most mandates.

The investable universe186 firms with 20+ employees
20–99
11863%
100–499
2614%
500+
4223%

A national duopoly sized on the dialysis-center code: DaVita and Fresenius run most of the ~500 firms, ~268 employees each. Growth is steady (~3.9%/yr) on rising diabetes and kidney-disease prevalence, but the two-player structure and Medicare/MA reimbursement leave little room for new consolidation plays.

NAICS 621492. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Recurring dialysis-treatment reimbursement (largely Medicare)

Key economics

Revenue per firm
$59,031,576
Revenue per employee
$209,317
Employees per firm
268.4
Recurring revenue
High

thrice-weekly recurring treatment

EBITDA margin
Reimbursement-policy-driven
Capex intensity
High

Characteristics

  • Balanced cost base: payroll is 25% of revenue, leaving room to scale margin without cutting staff
  • Moderate strategic-buyer pool: 42 firms exceed 500 employees, so a scaled asset has buyers, but not many
  • Consolidated duopoly (DaVita, Fresenius).
  • Chronic, recurring, largely Medicare-funded.
  • Shift toward integrated value-based kidney care.

NAICS 621492. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Dialysis majors
  • Value-based kidney-care platforms
  • Nephrology MSOs

What’s driving deals

  • Value-based kidney-care integration.
  • Chronic kidney-disease prevalence.
  • Reimbursement-policy dynamics.

Find Nephrology Management Organizations acquisition targets

Search Acquisera’s index for companies classified under Nephrology Management Organizations (4.10.13.4) and build a targeted deal pipeline.

Search companies